GEn1E Lifesciences YC-Bewerbung

Summer 2019Active

GEn1E Lifesciences durchlief Y Combinator im Summer 2019-Batch als ein Healthcare-Unternehmen. Unten: Was das Unternehmen tut, wer es gegründet hat und seine Bewerbung bei YC, Frage für Frage im echten YC-Formular rekonstruiert.

YC-Batch: Summer 2019
Branche: HealthcareTherapeutics
Status: Active
Gestartet: 2022

Gründer

Ritu LalFounder

Was GEn1E Lifesciences tut

GEn1E Lifesciences is a Clinical-stage, multi-target company with a unique AI platform. We develop novel, next-generation, immunomodulatory therapies for rare & inflammatory diseases with no effective treatments. Our team is supercharging the drug development cycle by applying AI to multiple-mechanism-of-action protein targets and their natural platform capabilities - creating novel therapeutics at an unprecedented pace. Our AI platform has enabled us to develop a purpose-built therapy for ARDS to reduce its $20 billion cost on society (just in the USA). GEn1E has built a rich pipeline of 21+ novel and selective immunomodulators and has plans to accelerate 2 additional devastating diseases (beyond their lead indication) to IND in the next 12 months. Our AI platform enables tremendous pace and capital efficiency as demonstrated by our progress in ~2 years with seed capital - a stark contrast to the typical spend of $100M+ and 7+ years exhibited in the pharmaceuticals / biotech industry. With ~90% of rare diseases having no therapeutic treatment at all, GEn1E is taking a giant swing that will hopefully bring life-saving therapies to the lives of patients in need. The team at GEn1E has decades of experience in drug development and machine learning. We graduated from YCombinator and Stanford-StartX in late 2019. We are based in Palo Alto, CA.

GEn1E Lifesciencess YC-Bewerbung, rekonstruiert

Y Combinator Bewerbung

GEn1E Lifesciences, Summer 2019 Batch. Die echten Fragen des Antrags, beantwortet aus öffentlichen Daten.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

GEn1E Lifesciences

Describe what your company does in 50 characters or less.

AI platform accelerating therapies for rare diseases

What is your company going to make? Please describe your product and what it does or will do.

We are building an AI platform that speeds up discovery and development of novel immunomodulatory therapies targeting multiple mechanisms at once. Our platform identifies and optimizes protein therapies for rare and inflammatory diseases with no current treatments. We've already developed a lead candidate for ARDS and a pipeline of 21+ selective immunomodulators.

Where do you live now, and where would the company be based after YC?

We live in Palo Alto, CA, and the company is based here.

Explain your decision regarding location.

Palo Alto puts us at the center of biotech and AI innovation, with access to top talent, investors, and collaborators. It's also where we're rooted personally and professionally.

21 weitere Antworten in der vollständigen Bewerbung

Founders, Progress, Idea, Equity, Curious, Batch Preference sind in der Vollversion. Erstelle ein kostenloses Konto, um es in YC Insights neben jedem anderen YC-Batch zu öffnen.

Vollständige Bewerbung anzeigen

Häufig gestellte Fragen

Ist das die echte YC-Bewerbung von GEn1E Lifesciences?

Nein. Y Combinator hält eingereichte Bewerbungen privat. Dies ist eine Rekonstruktion: die echten Fragen des YC-Formulars, beantwortet aus den öffentlichen Daten von GEn1E Lifesciences (Veröffentlichungsnotizen, Gründerhintergründe, Produktbeschreibung). Sie zeigt, wie sich ein Unternehmen wie GEn1E Lifesciences bei YC präsentieren würde, nicht den Text, den sie eingereicht haben.

In welchem YC-Batch war GEn1E Lifesciences?

GEn1E Lifesciences war Teil des Y Combinator Summer 2019-Batches.

Wer hat GEn1E Lifesciences gegründet?

GEn1E Lifesciences wurde von Ritu Lal gegründet.

Was macht GEn1E Lifesciences?

AI platform accelerating therapies for rare & inflammatory diseases.

Wie lese ich die vollständige, rekonstruierte Bewerbung?

Erstelle ein kostenloses Round Funded Konto. Die vollständige 26-Antwort-Version der Bewerbung von GEn1E Lifesciences, und jede andere YC-Kohorte, findest du in YC Insights.